ANI Pharmaceuticals's total assets for Q1 2026 were $1.42B, a decrease of -1.28% from the previous quarter. ANIP total liabilities were $859.67M for the fiscal quarter, a -4.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.